Herschorn, S., Nazir, J., Ramos, B. and Hakimi, Z. 2017. Supplementary data: Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada. Canadian Urological Association Journal. 11, 3-4 (Apr. 2017), E129–33. DOI:https://doi.org/10.5489/cuaj.4617.